Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-02
DOI
10.1038/s41598-017-07973-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of hypoxia inducible factor-1 alpha in matched hormone naive and castrate resistant prostate cancer specimens
- (2017) Beatrix Elsberger et al. Cancer Biomarkers
- Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
- (2016) Zhihong Ai et al. CANCER LETTERS
- BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10
- (2016) Kai Wu et al. CANCER LETTERS
- Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
- (2016) Junlian Gu et al. DIABETES
- miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells
- (2016) PENG ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation
- (2016) Jonathan D. Diedrich et al. Oncotarget
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer
- (2015) Shuang Li et al. CANCER BIOLOGY & THERAPY
- The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer
- (2015) Zhi Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of vascular endothelial growth factor siRNA and wild-type p53 co-expressing plasmid in MDA-MB-231 cells
- (2015) HUA GUO et al. Molecular Medicine Reports
- Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations
- (2015) Bradley A. Webb et al. NATURE
- eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation
- (2015) Yu Zhang et al. Oncotarget
- Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells
- (2015) Takumi Shiraishi et al. Oncotarget
- Murine Double Minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo
- (2014) Junlian Gu et al. EUROPEAN JOURNAL OF CANCER
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targetingSalmonella
- (2014) Jiaqi Deng et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth
- (2014) Lei Wang et al. Cell Reports
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
- (2013) Krushna C. Patra et al. CANCER CELL
- Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer
- (2013) D Li et al. CANCER GENE THERAPY
- Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo
- (2013) Xin Li et al. CANCER LETTERS
- Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA
- (2013) Tao Jiang et al. CANCER LETTERS
- Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo
- (2013) Junlian Gu et al. CANCER LETTERS
- Hypoxia-inducible factor 1 contributes to N-acetylcysteine’s protection in stroke
- (2013) Ziyan Zhang et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Role of Hypoxia-Inducible Factor 1α in Determining the Properties of Castrate-Resistant Prostate Cancers
- (2013) Weranja K. B. Ranasinghe et al. PLoS One
- HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs
- (2011) Carolyn Culver et al. CELL CYCLE
- Synergistic Suppression of Prostatic Cancer Cells by Coexpression of Both Murine Double Minute 2 Small Interfering RNA and Wild-Type p53 Gene In Vitro and In Vivo
- (2011) K. Ji et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice
- (2011) Y. Bai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
- (2009) Divya Pathania et al. ADVANCED DRUG DELIVERY REVIEWS
- HIF-1: upstream and downstream of cancer metabolism
- (2009) Gregg L Semenza CURRENT OPINION IN GENETICS & DEVELOPMENT
- Glucose up-regulates HIF-1α expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status
- (2008) Shuhong Guo et al. JOURNAL OF NEUROCHEMISTRY
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More